<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2006</study_start_year><condition>Colorectal Neoplasms</condition><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2039027</full_dataset_link><location>United States</location><study_start_month>1</study_start_month><keyword>GI neoplasms (phase 1)</keyword><keyword>Axitinib</keyword><keyword>Bevacizumab</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer</name><description>To determine the safety and efficacy of AG-013736 in combination with other standard of care medication in patients with first line metastatic colorectal cancer.</description><dates><creation>2006-01-15</creation></dates><accession>2039027</accession><cross_references><ClinicalTrials___gov>NCT00460603</ClinicalTrials___gov></cross_references></HashMap>